Dallas, TX (PRWEB) February 01, 2014
US Health Group, a leading ancillary service provider, has established a new partnership with Dallas-based Medicus Laboratories, LLC to provide compliant drug-monitoring solutions that help physicians and other healthcare professionals eliminate unnecessary treatments and their related expenses.
The partnership will integrate unique drug-monitoring programs into physician in-office laboratories. The two companies will collaborate to provide effective, compliant and cost effective toxicology solutions to physicians and other healthcare providers, using technology’s most advanced LCMS equipment. Physician practices will benefit from exclusive industry perspectives on quality control and assessment procedures, equipment lease or purchase options, scheduling of laboratory technicians, and consultation on revenue maximization and cost reduction.
“Partnering with Medicus Laboratories will allow us to present physicians with drug-monitoring programs tailored to individual practice needs as a solution to help protect against the misuse of controlled substances,” said a representative of US Health Group. “Our goal for the partnership is to provide physicians and other healthcare professionals with standard operating, quality control, and assessment procedures related to therapeutic drug monitoring as a recommended ancillary service.”
About Medicus Laboratories, LLC
Medicus Laboratories’ drug monitoring programs are transforming physician in office laboratories. Medicus Laboratories works directly with physicians to design and implement CLIA-approved laboratories that substantially reduce costs for physician practices and improve patient safety and the healthcare system as a whole.
About US Health Group
US Health Group is the parent company designed to provide physicians and healthcare professionals with a single, integrated partner for all of their ancillary needs in an effort to improve both overall patient care and practice security.